Clinical Trials

12 enrolled

Pancreatic Neoplasms

NCT06172322 2024-04-23

A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer

42 enrolled

Breast

HR Positive/HER-2 Negative Breast Cancer

NCT05735028 2024-04-17

The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer

8 enrolled

Thoracic

Lung Neoplasms

NCT05483530 2024-04-16

A Study to Investigate the Safety, Tolerability and Efficacy of HLX60 Combination With HLX10 in Subjects With Advanced or Metastatic Solid Tumors

20 enrolled

Advanced or Metastatic Solid Tumors

NCT05606380 2024-04-16

A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or Lymphoma

11 enrolled

Lymphoid

Lymphoma

NCT06356701 2024-04-10

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

120 enrolled

Thoracic

Lung Neoplasms

NCT06348290 2024-04-04

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

72 enrolled

Solid Tumor, Adult

NCT06344715 2024-04-03

Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.

78 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

71 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05394168 2024-04-01

A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors

12 enrolled

Advanced/Metastatic Solid Tumors

NCT03560882 2024-03-21

A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

MyeloidOther hematologic neoplasm

50 enrolled

Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT05193721 2024-03-20

A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors

25 enrolled

Advanced Malignant Tumors

NCT05037149 2024-03-18

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

50 enrolled

Solid Tumor

NCT05646758 2024-03-18

A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects

140 enrolled

Plasma cell

Multiple Myeloma

NCT03291444 2024-03-15

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

MyeloidOther hematologic neoplasm

30 enrolled

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05783570 2024-03-15

To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307

12 enrolled

Carcinoma, Hepatocellular

NCT04671875 2024-03-13

A Clinical Study of MIL93 in Solid Tumors.

228 enrolled

Advanced Malignancies

NCT05475210 2024-03-13

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

9 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT05798026 2024-03-13

A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy

15 enrolled

Solid Tumor

NCT06139536 2024-03-13

Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients

210 enrolled

Advanced Solid Tumor

NCT05103046 2024-03-12

First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

68 enrolled

Advanced Solid Tumor

NCT05872867 2024-03-12

MK-3475-E90

GastrointestinalHead & NeckThoracic

54 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05894421 2024-03-12

TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers

92 enrolled

Advanced Cancer

NCT06304597 2024-03-12

PREDICT

18 enrolled

Locally Advanced Rectal Carcinoma

NCT06307093 2024-03-12

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

DermatologicHead & NeckThoracic

90 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Lung Neoplasms, Melanoma, Neoplasms

NCT06300489 2024-03-08

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

30 enrolled

Rectal Neoplasms

NCT04544748 2024-03-06

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

DermatologicGenitourinaryThoracic

48 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT04766320 2024-03-06

Study on TIL for the Treatment of r/r Gynecologic Tumors

15 enrolled

Gynecologic

Gynecologic Cancer

NCT05472857 2024-03-06

Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression

30 enrolled

Pancreatic Neoplasms, Stomach Neoplasms

NCT06225921 2024-03-06

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

6 enrolled

Esophageal Squamous Cell Carcinoma

NCT06292858 2024-03-05

Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors

93 enrolled

Neoplasm Metastasis, Recurrence

NCT06283303 2024-02-29

A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

8 enrolled

Colorectal Neoplasms

NCT05836623 2024-02-28

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

5 enrolled